Table 3. Differences in SPME-GC-MS peaks and concentrations of biomarkers between pairs of urine mixture samples for healthy volunteers, patients with bladder cancer, and patients with prostate cancer (continued).

Peak #

Compound

parameters

Healthy volunteers

Bladder cancer
(post-antibiotic pro.)

Bladder cancer

Prostate cancer (endocrine therapy)

Prostate cancer

H1–3

H4–6

post-TUR K:Um

pre-TUR K:Um

post-TUR N:Um

pre-TUR N:Um

post-RP Pe:Um

pre-RP Pe:Um

post-RP P:Um

pre-RP P:Um

70

unidentified

peak height

1.6×104

1.5×104

1.8×104

2.1×104

1.6×104

1.7×104

1.7×104

1.9×104

1.2×104

1.9×104

relat.to_healthy Um

1.00

0.92

1.11

1.27

0.98

1.05

1.01

1.13

0.75

1.13

relat.to_#70

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

relat.to_#36

0.17

0.18

0.18

0.13

0.18

0.18

0.16

0.18

0.17

0.15

36

unidentified

peak height

9.7×104

8.5×104

9.9×104

1.6×105

9.0×104

9.7×104

1.1×105

1.0×105

7.2×104

1.2×105

relat.to_healthy Um

1.00

0.88

1.02

1.65

0.93

1.00

1.10

1.07

0.74

1.25

relat.to_#70

5.90

5.59

5.44

7.65

5.65

5.64

6.42

5.57

5.87

6.50

relat.to_#36

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

87

unidentified

peak height

4,158

3,619

3,115

2,540

2,241

2,364

2,819

3,662

1,936

1,789

relat.to_healthy Um

1.00

0.87

0.75

0.61

0.54

0.57

0.68

0.88

0.47

0.43

relat.to_#70

0.25

0.24

0.17

0.12

0.14

0.14

0.17

0.20

0.16

0.10

relat.to_#36

0.04

0.04

0.03

0.02

0.02

0.02

0.03

0.04

0.03

0.01

92

unidentified

peak height

1,771

1,387

2,157

1,495

1,722

1,147

2,195

1,720

1,612

2,099

relat.to_healthy Um

1.00

0.78

1.22

0.84

0.97

0.65

1.24

0.97

0.91

1.19

relat.to_#70

0.11

0.09

0.12

0.07

0.11

0.07

0.13

0.09

0.13

0.11

relat.to_#36

0.018

0.016

0.022

0.009

0.019

0.012

0.021

0.017

0.022

0.017

post-antibiotic pro.: post-TUR K:Um with antibiotic prophylaxis; TUR: Transurethral Resection; RP: Radical Prostatectomy.

All patient samples were mixtures of 25 urine samples (5 patients × 5 samples). DB-5MS column is equivalent to CP Sil 8CB column. Ratio of the peak height for the respective sample relative (relat.) to that of an average of those for H1–3 and H4–6 mixture samples Um. >10-fold (red) and 2–10-fold (blue) increases from the peak height of the healthy volunteer in were highlighted.